Self-calibrating ultrasensitive biosensing platform based on multifunctional nanocomposites and DNAzyme-assisted CRISPR/Cas12a system for accurate TGF-β1 quantification in liver fibrosis assessment
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Self-calibrating ultrasensitive biosensing platform based on multifunctional nanocomposites and DNAzyme-assisted CRISPR/Cas12a system for accurate TGF-β1 quantification in liver fibrosis assessment | Researchclopedia